The importance of sign and symptoms assessment in patients with metastatic renal cell carcinoma: implications for cytoreductive nephrectomy by A. Larcher, G. Fallara, G. Rosiello, G. Basile, C. Re, G. Baiamonte, S. Agnesi, D. Cignoli, G. Colandrea, A. Briganti, R. Bertini, A. Salonia, F. Montorsi, U. Capitanio

Get full text

Pathological features and predictors of oncologic outcomes in patients with small renal masses by R. Bertini, G. Rosiello, F. Muttin, G. Baiamonte, C. Re, S. Agnesi, C. Bravi, M. Bandini, G. Basile, D. Cignoli, A. Briganti, A. Salonia, F. Montorsi, U. Capitanio, A. Larcher

Get full text

Is whenever feasible-strategy for partial nephrectomy invariably justified? the impact of clinical tumour size on postoperative renal function by G. Fallara, A. Larcher, G. Rosiello, G. Basile, D. Cignoli, G. Colandrea, A. Martini, W. Cazzaniga, C.A. Bravi, M. Bandini, G. Baiamonte, A. Briganti, A. Salonia, R. Bertini, F. Montorsi, U. Capitanio

Get full text

Association between BRCA 1/2 polymorphisms and disease aggressiveness in a prospective cohort of prostate cancer patients undergoing radical prostatectomy by V. Cucchiara, D. Lazarevic, D. Cittaro, M. Zoccolillo, M. Bianchi, N. Longo, S. Scuderi, F. Barletta, A. Martini, E. Mazzone, G. Basile, G.O. Cirulli, D. Cignoli, M. Tutolo, N. Fossati, G. Gandaglia, V. Mirone, F. Montorsi, G. Tonon, A. Briganti

Get full text

The inverse correlation between obesity and mortality in patients with metastatic castration resistant prostate cancer: Results from the control arms of ASCENT2, MAINSAL and VENICE... by D. Cignoli, A. Martini, J.P. Sfakianos, G. Gandaglia, N. Fossati, A. Salonia, F. Barletta, S. Scuderi, D. Robesti, C.A. Bravi, E. Mazzone, G. Rosiello, G. Fallara, L. Nocera, G.O. Cirulli, A. Stabile, A. Briganti, F. Montorsi, W.K. Oh, E.D. Gallagher, M.D. Galsky

Get full text

Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma: results from the national cancer database by G. Sorce, A. Martini, J. Pfail, U.G. Falgario, N. Waingankar, G. Gandaglia, N. Fossati, G. Fallara, F. Barletta, S. Scuderi, D. Robesti, D. Cannoletta, D. Cignoli, G. Basile, L. Nocera, G. Rosiello, E. Mazzone, C.A. Bravi, A. Necchi, F. Montorsi, A. Briganti, M.D. Galsky, J.P. Sfakianos

Get full text

The relationship between percentage PSA reduction and rate of failure after focal therapy for prostate cancer by G.O. Cirulli, A. Stabile, G. Gandaglia, N. Fossati, C. Orczyc, F. Giganti, S. Scuderi, V. Cucchiara, D. Cignoli, E. Zaffuto, F. Barletta, F. Pellegrino, E. Vecchio, M. Moschini, N. Cathala, P. Macek, H.U. Ahmed, M. Emberton, X. Cathelineau, A. Briganti, F. Montorsi, R.Sanchez Salas, C.M. Moore

Get full text

Should we target all visible areas at mpMRI suspicious for clinically significant prostate cancer in addition to the index lesion? Results from a two-institution series by F. Scalvi, A. Stabile, R.J. Karnes, G. Motterle, N. Fossati, G. Gandaglia, F. Barletta, S. Scuderi, V. Cucchiara, L. Nocera, E. Zaffuto, D. Cignoli, G. Rosiello, D. Robesti, D. Cannoletta, E. Zito, M. Menean, E. Mazzone, P. Dell’Oglio, A. Salonia, P.I. Karakiewicz, F. Montorsi, F. De Cobelli, A. Briganti

Get full text

Initial negative multi-parametric MRI with concomitant negative biopsy: Are true negative findings confirmed over time? Results from a single institution series by E. Mazzone, A. Stabile, N. Fossati, E. Zaffuto, G. Gandaglia, D. Robesti, D. Cannoletta, M. Menean, D. Cignoli, F. Pellegrino, C.A. Bravi, S. Comana, V. Cucchiara, G. Fallara, P. Dell’Oglio, A. Martini, M. Moschini, A. Rizzo, A. Necchi, A. Salonia, P.I. Karakiewicz, F. Montorsi, F. De Cobelli, A. Briganti

Get full text